GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Easywell Biomedicals 1799.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

24.90

+0.61%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Easywell Biomedicals

Its shares trade on Taipei Exchange under the ticker 1799.TWO. It has been listed since 8 February 2007. In the fiscal year to 31 December 2025, it reported revenue of TWD 597.4m and a net loss of TWD 73.1m. At that date it held total assets of TWD 1.29bn and shareholders' equity of TWD 690.7m.

Easywell Biomedicals, Inc. engages in the manufacture and sale of pharmaceutical products and medical equipment. The company is headquartered in Hsinchu, Hsinchu. The company went IPO on 2007-02-08. The raw materials are applied in the manufacture of medicament for the treatment of epilepsy, pain and fever, antihypertensive and diuretic, skeletal muscle relaxants, among others. The firm's diagnostic devices include ear thermometers and digital clinical thermometers. The firm distributes its products mainly in Taiwan, the Americas and Europe.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
8 Feb 2007
Employees
286

Leadership

Pay as last reported

  • Mr. Han-Fei LinChairman of the Board, Chief Executive Officer, since 2018
  • James LeeGeneral Manager, since 2017
  • Jianlun MaDeputy General Manager
  • Xuejun WuHead of Finance & Accounting, Corporate Governance Officer
  • Mr. Howard LeeDirector, since 2007
  • Qiuyue LiDirector
  • Zhicheng ZhangDirector
  • Zhaorong ChenIndependent Director
  • Zhigang GeIndependent Director
  • Jizhou LiaoIndependent Director
  • Ms. Yuya LinIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Hsinchu, Taiwan, with a focus on pharmaceuticals and medical equipment.
  • Offers a diverse product range including diagnostic devices like ear thermometers.
  • Operates in multiple regions including Taiwan, the Americas, and Europe.

Weaknesses

  • Relies on raw materials for medicaments treating specific conditions like epilepsy and hypertension.
  • Limited to manufacturing and sales without mention of R&D or innovation.
  • No indication of financial performance or market share data provided.

Opportunities

  • Expanding into new markets beyond current regions of operation.
  • Increasing demand for diagnostic devices such as thermometers globally.
  • Potential for growth in pharmaceutical markets for treatments of chronic conditions.

Threats

  • Dependence on specific raw materials for product manufacturing.
  • Competition in the pharmaceutical and medical equipment sectors.
  • Reliance on regional markets which may face economic or regulatory challenges.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.